Literature DB >> 24737588

Expression and biological role of cytoglobin in human ovarian cancer.

Haiying Chen1, Xia Zhao, Tao Meng.   

Abstract

Loss of cytoglobin is found to be involved in the progression of several human cancers. However, its expression pattern and biological roles in human ovarian cancers are not clear. In this study, we examined cytoglobin expression in 118 archived ovarian cancer specimens using immunohistochemistry. A total of 72 specimens (61.0 %) showed cytoglobin downregulation. cytoglobin downregulation positively correlated with advanced FIGO stage and tumor grade. Cytoglobin plasmid transfection was performed in SKOV3 cell line and siRNA knockdown was carried out in SW626 cell line. MTT, colony formation assay and matrigel invasion assay were carried out to assess the role of cytoglobin on cell proliferation and invasion. Cytoglobin overexpression inhibited cell growth, invasion, cell cycle progression and cyclin D1 expression in SKOV3 cell line and its depletion promoted cell proliferation, invasion, cell cycle transition and cyclin D1 expression. In conclusion, cytoglobin is downregulated in ovarian cancers and associated with advanced stage. Our data provides evidence that cytoglobin regulates the ovarian cancer cell proliferation and invasion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24737588     DOI: 10.1007/s13277-014-1941-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

Review 1.  Functional adaptation and its molecular basis in vertebrate hemoglobins, neuroglobins and cytoglobins.

Authors:  Roy E Weber; Angela Fago
Journal:  Respir Physiol Neurobiol       Date:  2004-12-15       Impact factor: 1.931

2.  miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor.

Authors:  Jinling Guo; Bairong Xia; Fanling Meng; Ge Lou
Journal:  Tumour Biol       Date:  2013-10-15

3.  Cytoglobin: a novel globin type ubiquitously expressed in vertebrate tissues.

Authors:  Thorsten Burmester; Bettina Ebner; Bettina Weich; Thomas Hankeln
Journal:  Mol Biol Evol       Date:  2002-04       Impact factor: 16.240

Review 4.  Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapies.

Authors:  Kathleen M Darcy; Michael J Birrer
Journal:  Gynecol Oncol       Date:  2010-03-16       Impact factor: 5.482

5.  Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer.

Authors:  George Xinarianos; Fiona E McRonald; Janet M Risk; Naomi L Bowers; Georgios Nikolaidis; John K Field; Triantafillos Liloglou
Journal:  Hum Mol Genet       Date:  2006-05-12       Impact factor: 6.150

6.  Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer.

Authors:  R J Shaw; M M Omar; S Rokadiya; F A Kogera; D Lowe; G L Hall; J A Woolgar; J Homer; T Liloglou; J K Field; J M Risk
Journal:  Br J Cancer       Date:  2009-07-07       Impact factor: 7.640

7.  Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.

Authors:  Chioniso Patience Masamha; Doris Mangiaracina Benbrook
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

Review 8.  Epidemiology of ovarian cancer.

Authors:  Jennifer Permuth-Wey; Thomas A Sellers
Journal:  Methods Mol Biol       Date:  2009

9.  Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma.

Authors:  T Ishikawa; M Furihata; Y Ohtsuki; H Murakami; A Inoue; S Ogoshi
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

10.  The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients.

Authors:  Hong-Wu Xu; Yue-Jun Huang; Ze-Yu Xie; Lan Lin; Yan-Chun Guo; Ze-Rui Zhuang; Xin-Peng Lin; Wen Zhou; Mu Li; Hai-Hua Huang; Xiao-Long Wei; Kwan Man; Guo-Jun Zhang
Journal:  BMC Cancer       Date:  2013-05-20       Impact factor: 4.430

View more
  7 in total

1.  Is the Mitochondrial Function of Keloid Fibroblasts Affected by Cytoglobin?

Authors:  Sri Widia A Jusman; Isma Nur Azzizah; Mohamad Sadikin; Novi Silvia Hardiany
Journal:  Malays J Med Sci       Date:  2021-04-21

2.  Cytoglobin protects cancer cells from apoptosis by regulation of mitochondrial cardiolipin.

Authors:  Lorna S Thorne; Garret Rochford; Timothy D Williams; Andrew D Southam; Giovanny Rodriguez-Blanco; Warwick B Dunn; Nikolas J Hodges
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 3.  Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?

Authors:  Priyanka Shaw; Naresh Kumar; Maxime Sahun; Evelien Smits; Annemie Bogaerts; Angela Privat-Maldonado
Journal:  Biomedicines       Date:  2022-03-31

4.  Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species.

Authors:  Dinh Viet Hoang; Le Thi Thanh Thuy; Hoang Hai; Vu Ngoc Hieu; Kenjiro Kimura; Daisuke Oikawa; Yoshihiro Ikura; Ninh Quoc Dat; Truong Huu Hoang; Misako Sato-Matsubara; Minh Phuong Dong; Ngo Vinh Hanh; Sawako Uchida-Kobayashi; Fuminori Tokunaga; Shoji Kubo; Naoko Ohtani; Katsutoshi Yoshizato; Norifumi Kawada
Journal:  Oncogenesis       Date:  2022-05-03       Impact factor: 6.524

Review 5.  Cytoglobin as a Biomarker in Cancer: Potential Perspective for Diagnosis and Management.

Authors:  Tatsha C Bholah; Vidushi S Neergheen-Bhujun; Nikolas J Hodges; Sabrina D Dyall; Theeshan Bahorun
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

Review 6.  Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts.

Authors:  Norifumi Kawada
Journal:  Front Physiol       Date:  2015-11-13       Impact factor: 4.566

Review 7.  Emerging perspectives on cytoglobin, beyond NO dioxygenase and peroxidase.

Authors:  Clinton Mathai; Frances L Jourd'heuil; Reynold I Lopez-Soler; David Jourd'heuil
Journal:  Redox Biol       Date:  2020-02-14       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.